The total Non-small cell lung cancer incident cases in the 7MM were observed to be 484,726 cases in the year 2017. Non-Small cell lung cancer market is anticipated to increase in the 7MM from USD 9,730 million in 2017 by 2030. Key players such as AstraZeneca, Bristol Myers Squ...